https://www.selleckchem.com/pr....oducts/cbr-470-1.htm
Autologous haematopoietic stem cell transplantation (AHSCT) is a treatment option for aggressive forms of multiple sclerosis (MS) that has been derived from haematological indications and repurposed for treatment of refractory autoimmune diseases. In the present review, a search for clinical studies on AHSCT was performed on the PubMed website and ClinicalTrials.gov databases. Papers were selected according to the following criteria text written in English language, publication date between 2014 and August 2019, and reports including
Aimer
Commentaire
Partagez
